KYMR
Price
$55.77
Change
-$2.55 (-4.37%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
3.99B
7 days until earnings call
Intraday Buy/Sell Signals
NTLA
Price
$24.56
Change
-$2.41 (-8.94%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
2.64B
14 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

KYMR vs NTLA

Header iconKYMR vs NTLA Comparison
Open Charts KYMR vs NTLABanner chart's image
Kymera Therapeutics
Price$55.77
Change-$2.55 (-4.37%)
Volume$27.48K
Capitalization3.99B
Intellia Therapeutics
Price$24.56
Change-$2.41 (-8.94%)
Volume$62.79K
Capitalization2.64B
KYMR vs NTLA Comparison Chart in %
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. NTLA commentary
Oct 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 23, 2025
Stock price -- (KYMR: $55.80 vs. NTLA: $24.58)
Brand notoriety: KYMR and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 100% vs. NTLA: 103%
Market capitalization -- KYMR: $3.99B vs. NTLA: $2.64B
KYMR [@Biotechnology] is valued at $3.99B. NTLA’s [@Biotechnology] market capitalization is $2.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $109.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 0 green, 5 red.
According to our system of comparison, NTLA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 2 TA indicator(s) are bullish while NTLA’s TA Score has 2 bullish TA indicator(s).

  • KYMR’s TA Score: 2 bullish, 6 bearish.
  • NTLA’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -11.27% price change this week, while NTLA (@Biotechnology) price change was -5.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.28%. For the same industry, the average monthly price growth was +10.37%, and the average quarterly price growth was +61.79%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

NTLA is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-2.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.99B) has a higher market cap than NTLA($2.64B). NTLA YTD gains are higher at: 110.806 vs. KYMR (38.702). KYMR has higher annual earnings (EBITDA): -267.03M vs. NTLA (-501.87M). KYMR has more cash in the bank: 665M vs. NTLA (460M). KYMR has less debt than NTLA: KYMR (85.7M) vs NTLA (103M). NTLA has higher revenues than KYMR: NTLA (52.9M) vs KYMR (44.7M).
KYMRNTLAKYMR / NTLA
Capitalization3.99B2.64B151%
EBITDA-267.03M-501.87M53%
Gain YTD38.702110.80635%
P/E RatioN/AN/A-
Revenue44.7M52.9M84%
Total Cash665M460M145%
Total Debt85.7M103M83%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRNTLA
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HHCCX15.71N/A
N/A
NexPoint Event Driven C
LSRCX1.89N/A
N/A
Lord Abbett Small Cap Value C
ALVCX24.27N/A
N/A
American Beacon Large Cap Value C
GTCSX31.46-0.17
-0.54%
Glenmede Small Cap Equity Adv
ANFCX61.17-0.58
-0.94%
American Funds New Economy C